(1E)-4-(3-(naphthalen-2-yl)-3-oxoprop-1-en-1-yl)benzaldehyde | 1026619-69-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (1E)-4-(3-(naphthalen-2-yl)-3-oxoprop-1-en-1-yl)benzaldehyde
• 英文别名: (E)-4-(3-(naphthalen-2-yl)-3-oxo-propenyl)benzaldehyde；4-[(E)-3-naphthalen-2-yl-3-oxoprop-1-enyl]benzaldehyde
• CAS: 1026619-69-1
• 化学式: C₂₀H₁₄O₂
• 分子量: 286.33
• InChiKey: JSVJMEDNEDFVPN-FMIVXFBMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (1E)-4-(3-(naphthalen-2-yl)-3-oxoprop-1-en-1-yl)benzaldehyde 在 三乙酰氧基硼氢化钠 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 、 乙酰氯 作用下， 以 顺-1,2-二氯乙烯 、 甲醇 、 氯仿 、 N,N-二甲基甲酰胺 为溶剂， 反应 72.08h， 生成 (E)-2,6-bis(chloroamino)-N-(4-(3-(naphthalen-2-yl)-3-oxoprop-1-en-1-yl)benzyl)-N-nonylhexanamide
  参考文献：
  名称：

  Antibacterial efficacy evaluation and mechanism probe of small lysine chalcone peptide mimics

  摘要：

  DOI：

  10.1016/j.ejmech.2022.114885
• 作为产物：
  描述：

  对苯二甲醛 、 2-萘乙酮 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 0.17h， 以90%的产率得到(1E)-4-(3-(naphthalen-2-yl)-3-oxoprop-1-en-1-yl)benzaldehyde
  参考文献：
  名称：

  Synthesis of flavonoids based novel tetrahydropyran conjugates (Prins products) and their antiproliferative activity against human cancer cell lines

  摘要：

  Following our previously reported Prins cyclization strategy, a series of novel and highly functionalized flavonoid based THPs (Prins products) were designed, synthesized and evaluated for their anti-proliferative activity. Novel products were afforded in excellent yields (72-96%) within 20-90 min at 62 degrees C using flavonoid aldehydes, homoallylic alcohols, p-TSA center dot H2O (catalyst and reagent) and MS 4 angstrom in CHCl3. Deprotection of tosyl group was achieved with TFA (catalyst and solvent) at 140 degrees C to obtain 4-hydroxytetrahydropyrans and further reaction of 4-hydroxytetrahydropyrans with cinnamoyl chloride afforded 4-cinnamate tetrahydropyrans under neat condition. Synthesized compounds evaluated against human cancer cell lines (Hep3 beta, MCF-7 and Hela), have shown moderate to good antiproliferative activity in vivo. Compounds 3q and 3zb exhibited similar cytotoxicity (IC50 6.6 +/- 1.4, 6.9 +/- 1.0 mu M, respectively) to the reference drug doxorubicin (IC50 7.6 +/- 0.9 mu M) against the MCF-7 cancer cell line. Compound 3zb was found equally active as the standard drug (IC50 4.48 +/- 2.1 mu M) against the Hep3 beta cell line and compounds 3c and 3q showed moderate cytotoxicity (IC50 10.40 +/- 1.1, 12.9 +/- 1.7 mu M, respectively) against the HeLa cell line. (C) 2014 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2014.01.033

文献信息

• Synthesis and biological evaluation of (<i>E</i>)-1-(substituted)-3-phenylprop-2-en-1-ones bearing rhodanines as potent anti-microbial agents
  作者：Ming-Xia Song、Xian-Qing Deng、Ya-Ru Li、Chang-Ji Zheng、Lan Hong、Hu-Ri Piao

  DOI：10.3109/14756366.2013.837899

  日期：2014.10.1

  Herein, we report the design, syntheses and in vitro anti-microbial activity of two series of rhodanines with chalcone moiety. Anti-microbial tests showed that some of the synthesized compounds exhibited good inhibition (MIC = 1-8 µg/mL) against multi-drug-resistant Gram-positive organisms, including methicillin resistant and quinolone-resistant Staphylococcus aureus, in which the compound 4g was found to be the most potent with minimum inhibitory concentration (MIC) value of 1 µg/mL against two methicillin-resistant S. aureus.
• Synthesis and antimicrobial evaluation of l-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone
  作者：Xin Jin、Chang-Ji Zheng、Ming-Xia Song、Yan Wu、Liang-Peng Sun、Yin-Jing Li、Li-Jun Yu、Hu-Ri Piao

  DOI：10.1016/j.ejmech.2012.08.026

  日期：2012.10

  Four novel series of compounds, including the L-phenylalanine-derived C5-substituted rhodanine (6a-q, 7a-j) and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone (9a-e, 11a-e) have been designed, synthesized, characterized, and evaluated for their antibacterial activity. Some of these compounds showed significant antibacterial activity against Gram-positive bacterias, especially against the strains of multidrug-resistant clinical isolates, among which compounds 6c-e, 6g, 6i, 6j and 6q exhibiting high levels of antimicrobial activity against Staphylococcus aureus RN4220 with minimum inhibitory concentration (MIC) values of 2 mu g/mL. Compound 6q showed the most potent activity of all of the compounds against all of the test multidrug-resistant clinical isolates tested. Unfortunately, however, none of the compounds were active against Gram-negative bacteria at 64 mu g/mL. (C) 2012 Elsevier Masson SAS. All rights reserved.